Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
Completed · Not applicable
Conditions studied: End Stage Renal Disease, Hyperhomocysteinemia
In brief
OBJECTIVES: I. Compare the efficacy of two doses of folic acid in normalizing plasma total homocysteine concentration in patients with end stage renal disease receiving regular hemodialysis therapy resulting in hyperhomocysteinemia. II. Determine the requirement of co-supplementation with extra pyridoxine (vitamin B6) and cyanocobalamin (vitamin B12) daily in these patients. III. Assess the safety and tolerability of this therapy in these patients.
Key facts
- Study ID
- NCT00004495
- Run by
- Georgetown University
- People needed
- 84
- Starts
- 1999-06-01
- Expected to finish
- 2000-09-01
- Last updated by the study team
- 2015-03-25
Who can join
Age: 21 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Georgetown University Medical Center — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.